Loring Wolcott & Coolidge Fiduciary Advisors’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-975
Closed -$31K 792
2020
Q3
$31K Hold
975
﹤0.01% 436
2020
Q2
$35K Hold
975
﹤0.01% 409
2020
Q1
$28K Hold
975
﹤0.01% 429
2019
Q4
$23K Hold
975
﹤0.01% 526
2019
Q3
$18K Hold
975
﹤0.01% 529
2019
Q2
$15K Hold
975
﹤0.01% 536
2019
Q1
$22K Hold
975
﹤0.01% 515
2018
Q4
$23K Hold
975
﹤0.01% 498
2018
Q3
$32K Hold
975
﹤0.01% 456
2018
Q2
$43K Hold
975
﹤0.01% 442
2018
Q1
$41K Hold
975
﹤0.01% 465
2017
Q4
$44K Hold
975
﹤0.01% 450
2017
Q3
$32K Hold
975
﹤0.01% 467
2017
Q2
$46K Hold
975
﹤0.01% 425
2017
Q1
$20K Hold
975
﹤0.01% 491
2016
Q4
$22K Hold
975
﹤0.01% 467
2016
Q3
$20K Hold
975
﹤0.01% 477
2016
Q2
$18K Hold
975
﹤0.01% 493
2016
Q1
$17K Hold
975
﹤0.01% 495
2015
Q4
$17K Hold
975
﹤0.01% 524
2015
Q3
$17K Hold
975
﹤0.01% 501
2015
Q2
$17K Hold
975
﹤0.01% 501
2015
Q1
$16K Hold
975
﹤0.01% 526
2014
Q4
$14K Hold
975
﹤0.01% 532
2014
Q3
$13K Hold
975
﹤0.01% 515
2014
Q2
$13K Hold
975
﹤0.01% 541
2014
Q1
$13K Hold
975
﹤0.01% 525
2013
Q4
$16K Buy
+975
New +$15.2K ﹤0.01% 492

Other funds holding PETS

Loring Wolcott & Coolidge Fiduciary Advisors's PETS Position: Q4 2020 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of PetMed Express (PETS) in Q4 2020, closing a stake of 975 shares — an estimated $31K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in PETS in Q4 2013 and held it in 28 quarters. The position peaked at $46K in Q2 2017. 213 funds tracked by Wall St. Rank hold PETS as of Q4 2020.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining PetMed Express position as of Q4 2020 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 975 PetMed Express shares in Q4 2020, an estimated $31K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in PetMed Express in Q4 2013 and held it in 28 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's PetMed Express position peaked at $46K in Q2 2017.
  • 213 funds tracked by Wall St. Rank held PetMed Express as of Q4 2020.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2020, filed 14 Jan 2021.